ICON

ICON is a leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries. With a commitment to innovation and excellence, ICON supports clients in bringing their products to market efficiently and effectively.

Founded in 1990, ICON has grown significantly, now operating in over 40 countries with a workforce of more than 15,000 professionals. The company’s extensive experience spans all phases of clinical development, from early-phase studies to post-marketing surveillance.

Core Activities:

• Clinical Trial Management
• Regulatory Affairs Consulting
• Data Management and Biostatistics
• Market Access and Commercialisation Strategies

ICON prides itself on its client-centric approach, tailoring solutions to meet the unique needs of each project. The company leverages advanced technology and data analytics to enhance trial efficiency and improve patient outcomes.

With a strong focus on quality and compliance, ICON adheres to the highest industry standards, ensuring that all services are delivered with integrity and transparency. The company’s vision is to be the partner of choice for life sciences companies, helping them navigate the complexities of drug development.

As part of its commitment to corporate social responsibility, ICON actively engages in initiatives that promote health and well-being in communities around the world. This dedication to making a positive impact reflects the company’s core values and mission.